About
Male
Dan Hicklin, Ph.D., joined MPM in 2014 subsequent to his successful role as President & Chief Scientific Officer and member of the Board of CoStim Pharmaceuticals (acquired by Novartis:NVS). He now serves as President and CEO of Potenza Therapeutics, an immuno-oncology company founded by MPM. Dan is also a board member of Tizona Therapeutics and Harpoon Therapeutics, two MPM portfolio companies.
Experience
MPM Capital
View →Managing Director · 2014 – present
31Boston, Massachusetts, United StatesBiotechnology · Health Care
- President and CEO · Potenza Therapeutics2014 – present
- President and CEO · Werewolf Therapeutics
Education
- University of Iowa · BS, unknown
- New York Medical College · MS, PhD, Microbiology and Immunology
People at MPM Capital
Data from: crunchbase
